• $4.3M
    Market Cap
  • -89.47%
    1-Year Change
  • Real Estate Services
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 46
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Bronstein, Gewirtz & Grossman LLC Urges Concorde International Group, Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Concorde International Group, Ltd. (NASDAQ: CIGL) alleging securities fraud. The complaint claims defendants made materially false statements and failed to disclose a fraudulent stock promotion scheme involving social media misinformation, coordinated share dumping by insiders using offshore accounts, and artificial trading activity that inflated stock prices during the class period of April 21, 2025 to July 14, 2025.

04/15/2026, 12:00 PMGlobeNewswire

Stock Market Today: S&P 500, Dow, Nasdaq Futures Slide Amid US And Israel 'Operation Epic Furry' Against Iran— HKD, AARD, MDB In Focus (UPDATED)

U.S. stock futures fell sharply on Monday following geopolitical tensions with Iran, with the S&P 500, Dow Jones, and Nasdaq 100 all declining. The death of Iran's Supreme Leader and potential continuation of military strikes for weeks dampened market sentiment. Key movers included AMTD Digital surging 20% on strong revenue results, Aardvark Therapeutics plunging 53% after pausing a Phase 3 trial, and MongoDB dropping 2% ahead of earnings.

03/02/2026, 8:48 AMBenzinga

Avalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

Avalon GloboCare Corp. (NASDAQ: ALBT) closed a private placement raising $3.25 million upfront with up to $6.5 million in potential proceeds from warrant exercises. The company plans to use net proceeds for debt repayment and working capital. The offering included 6.37 million common shares and warrants priced at $0.51 per share.

02/27/2026, 5:30 PMGlobeNewswire

Avalon GloboCare Announces up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

Avalon GloboCare Corp. (NASDAQ: ALBT) announced a private placement of 6.37 million shares at $0.51 per share, generating $3.25 million in upfront proceeds with potential additional $6.5 million from warrant exercises. The company plans to use net proceeds for debt repayment and working capital. H.C. Wainwright & Co. is the exclusive placement agent.

02/26/2026, 9:20 PMGlobeNewswire

Avalon GloboCare Acquires RPM Interactive, a Generative AI Software Company, in an All-Stock Transaction

Avalon GloboCare has acquired RPM Interactive, a generative AI software company, in an all-stock transaction valued at $19.5 million. The acquisition creates a new subsidiary, Avalon Quantum AI, and is expected to help resolve Nasdaq's minimum stockholders' equity requirements.

12/15/2025, 8:30 AMBenzinga

EXCLUSIVE: Avalon GloboCare Buys AI Video Firm In 19.5 Million Deal

Avalon GloboCare has acquired RPM Interactive, an AI video software company, for $19.5 million in an all-stock transaction to enhance digital marketing capabilities and support its KetoAir product launch.

12/15/2025, 8:20 AMBenzinga

Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion

Avalon GloboCare expanded its KetoAir™ breathalyzer device internationally to the UK, launched a first responder wellness program in Nevada, and showcased its metabolic health monitoring technology at a London summit.

12/01/2025, 9:00 AMGlobeNewswire

Avalon GloboCare to Launch Online Sales of KetoAir Breathalyzer in the United Kingdom

Avalon GloboCare is launching its KetoAir breathalyzer device in the United Kingdom on September 1, 2025, targeting individuals pursuing ketogenic diets for health and wellness purposes.

08/28/2025, 9:00 AMGlobeNewswire

Peers

Statistics

More
Day Range
$0.35
$0.37
$0.37
1-Year Range
$0.30
$3.50
$0.37
Latest Close$0.37
Change
+$0.02 (+6.67%)
Volume339,248
Market Cap$4.3M
Shares Outstanding12.0M
P/E (TTM)-0.09
Diluted EPS (TTM)-$4.02
Enterprise Value$4.3M

Information as of 06/02/2026

Company Profile

$4.3M
Market Cap
-$20.3M
Net Income
Sector: Real Estate
Industry: Real Estate Services
4400 Route 9 South, Freehold, NJ, United States, 07728
732 780 4400

Avalon GloboCare Corp., together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in 2015 and is headquartered in Freehold, New Jersey.

Key Executives

  • Luisa Ingargiola
  • Meng Li

Current Ownership Distribution

  • Insiders34.7M (96.80%)
  • Mutual Funds631,790 (1.76%)
  • Institutions515,029 (1.44%)
  • Other0 (0.00%)